Bachem, PolyPeptide Group, AmbioPharm, CPC Scientific, CSBio) are expanding their peptide synthesis lines
FAQs What are GLP-1s and how do they work
It makes them feel unwell and puts them at risk of neurological damage
Research reveals both the potential and limits of fat-dissolving injection treatments for belly fat and abdominal areas
3 To Be Banned The colorant, Red No
The adverse events associated with GLP-1RA are predominantly GI, particularly nausea, vomiting, and diarrhea, and occur in 1050% of patients in clinical trials (Table 2) ( Pancreatitis and Pancreatic Cancer Since the introduction of GLP-1RA and DPP-4 inhibitors there has been some concern regarding the potential increase in pancreatitis and possibly pancreatic cancer with the incretin class of medications